Literature DB >> 8800984

Prognostic value of troponin T, myoglobin, and CK-MB mass in patients presenting with chest pain without acute myocardial infarction.

R J de Winter1, R W Koster, J H Schotveld, A Sturk, J P van Straalen, G T Sanders.   

Abstract

OBJECTIVE: To assess the prognostic value of minor myocardial damage in patients presenting with chest pain without myocardial infarction.
DESIGN: The relative risk of suffering a cardiac event in the next six months was assessed in patients with minor myocardial damage assessed by the cardiac markers CK-MB, myoglobin, and troponin T.
SETTING: Emergency department of a large university hospital. PATIENTS: In 128 consecutive patients with chest pain, acute myocardial infarction (by WHO criteria) was ruled out; of these, 39 had a rise and fall of one or more markers, indicating minor myocardial damage. The presence of a documented history of coronary artery disease was assessed on admission.
RESULTS: 24 patients had a subsequent event (cardiac death, acute myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting) in the next six months. An abnormal troponin T predicted a subsequent event while abnormal CK-MB or myoglobin did not. The relative risk for troponin T was 2.8 (95% confidence interval: 1.0 to 7.9), for myoglobin 1.0 (0.3 to 3.2), and for CK-MB 0.9 (0.2 to 3.4). A documented history of coronary artery disease predicted subsequent events with a relative risk of 3.9 (1.3 to 11.3).
CONCLUSIONS: Troponin T was the only marker that predicted future events, but a documented history of coronary artery disease was the best predictor in patients in whom an acute myocardial infarction had been ruled out.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8800984      PMCID: PMC484278          DOI: 10.1136/hrt.75.3.235

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  19 in total

Review 1.  Acute myocardial infarction and coronary reperfusion. Serum cardiac markers for the 1990s.

Authors:  F S Apple
Journal:  Am J Clin Pathol       Date:  1992-02       Impact factor: 2.493

2.  Development and in vitro characterization of a new immunoassay of cardiac troponin T.

Authors:  H A Katus; S Looser; K Hallermayer; A Remppis; T Scheffold; A Borgya; U Essig; U Geuss
Journal:  Clin Chem       Date:  1992-03       Impact factor: 8.327

3.  S-troponin-T as a marker of ischemic myocardial injury.

Authors:  W Gerhardt; H A Katus; J Ravkilde; C W Hamm
Journal:  Clin Chem       Date:  1992-06       Impact factor: 8.327

4.  Unstable angina. A classification.

Authors:  E Braunwald
Journal:  Circulation       Date:  1989-08       Impact factor: 29.690

Review 5.  Biochemical markers of myocardial injury. Is MB creatine kinase the choice for the 1990s?

Authors:  J E Adams; D R Abendschein; A S Jaffe
Journal:  Circulation       Date:  1993-08       Impact factor: 29.690

6.  Cardiac troponin T in diagnosis of acute myocardial infarction.

Authors:  J Mair; E Artner-Dworzak; P Lechleitner; J Smidt; I Wagner; F Dienstl; B Puschendorf
Journal:  Clin Chem       Date:  1991-06       Impact factor: 8.327

7.  S-troponin T in suspected ischemic myocardial injury compared with mass and catalytic concentrations of S-creatine kinase isoenzyme MB.

Authors:  W Gerhardt; H Katus; J Ravkilde; C Hamm; P J Jørgensen; E Peheim; L Ljungdahl; P Löfdahl
Journal:  Clin Chem       Date:  1991-08       Impact factor: 8.327

8.  Serum myoglobin levels in patients with ischemic myocardial insult.

Authors:  A Isakov; I Shapira; M Burke; C Almog
Journal:  Arch Intern Med       Date:  1988-08

9.  The prognostic value of serum troponin T in unstable angina.

Authors:  C W Hamm; J Ravkilde; W Gerhardt; P Jørgensen; E Peheim; L Ljungdahl; B Goldmann; H A Katus
Journal:  N Engl J Med       Date:  1992-07-16       Impact factor: 91.245

10.  Diagnostic efficiency of troponin T measurements in acute myocardial infarction.

Authors:  H A Katus; A Remppis; F J Neumann; T Scheffold; K W Diederich; G Vinar; A Noe; G Matern; W Kuebler
Journal:  Circulation       Date:  1991-03       Impact factor: 29.690

View more
  6 in total

1.  A double-blind, multicentered study comparing the accuracy of diagnostic markers to predict short- and long-term clinical events and their utility in patients presenting with chest pain.

Authors:  R Fromm; D Meyer; J Zimmerman; A Boudreaux; C C Wun; R Smalling; B Davis; G Habib; R Roberts
Journal:  Clin Cardiol       Date:  2001-07       Impact factor: 2.882

2.  Predictors of revascularization among emergency department patients who are evaluated for acute coronary syndrome.

Authors:  John T Nagurney; David Frank Brown; Claudia Chae; YuChiao Chang; Won Chung; Hilarie Cranmer; Li Dan; Jonathan Fisher; Shamai Grossman; Usha Tedrow; Kent Lewandrowski; Ik-Kyung Jang
Journal:  J Thromb Thrombolysis       Date:  2005-02       Impact factor: 2.300

3.  Myoglobin immunoassay based on metal particle-enhanced fluorescence.

Authors:  Evgenia G Matveeva; Zygmunt Gryczynski; Joseph R Lakowicz
Journal:  J Immunol Methods       Date:  2005-07       Impact factor: 2.303

4.  Utility of cardiac troponin I, creatine kinase-MB(mass), myosin light chain 1, and myoglobin in the early in-hospital triage of "high risk" patients with chest pain.

Authors:  G S Hillis; N Zhao; P Taggart; W C Dalsey; A Mangione
Journal:  Heart       Date:  1999-11       Impact factor: 5.994

5.  Partial and delayed release of troponin-I compared with the release of lactate dehydrogenase from necrotic cardiomyocytes.

Authors:  Lijuan Li; Marleen Hessel; Lizet van der Valk; Minka Bax; Irma van der Linden; Arnoud van der Laarse
Journal:  Pflugers Arch       Date:  2004-02-06       Impact factor: 3.657

6.  Circulating microRNA-208 family as early diagnostic biomarkers for acute myocardial infarction: A meta-analysis.

Authors:  Jia Wang; Liwenjing Xu; Lu Tian; Qiyu Sun
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.